3543 results for «2076»

Filter By

3543 results

Refractory heart failure: combining oral therapy and device is key

21 May 2025 – From EuroPCR 2025

Address refractory heart failure management through combined oral therapy and device interventions. This session helps identify patients needing treatment escalation, reviews contemporary cardiovascular intervention indications, and emphasizes achieving optimal synergy between pharmacologic and device-based therapies through clinical case discussions.

Refractory heart failure: combining oral therapy and device is key

TMVIV - TMVIR and its challenges

23 May 2025 – From EuroPCR 2025

Explore the challenges and innovations in transcatheter mitral valve-in-valve and valve-in-ring procedures. This session presents alternative access routes, management of paraannular compromise, and complex cases involving ECMO support and unexpected outcomes, offering valuable insights into advanced mitral interventions.

TMVIV - TMVIR and its challenges

When strange things happen, CTO and complications

23 May 2025 – From EuroPCR 2025

This session addresses complications and unexpected challenges encountered in chronic total occlusion (CTO) interventions. Learn from cases involving retrieval of stuck wires, coronary perforations, and strategies to manage complex and unusual procedural difficulties.

When strange things happen, CTO and complications

Challenges and complications in coronary interventions

23 May 2025 – From EuroPCR 2025

Discuss real-world challenges and complications in coronary interventions including heavily calcified LAD PCI, cardiac crisis management, and rare intramural hematoma cases. The session emphasizes the importance of IVUS guidance and operator expertise in complex scenarios.

Challenges and complications in coronary interventions

Navigating complexity in high-risk patients with multivessel disease undergoing PCI

23 May 2025 – From EuroPCR 2025

This educational session focuses on navigating the complexities of PCI in high-risk patients with multivessel disease. Learn the roles of imaging and physiology, low-contrast PCI techniques, and optimal strategies for patients with concomitant aortic stenosis, illustrated through detailed case discussions.

Navigating complexity in high-risk patients with multivessel disease undergoing PCI

Essential role of imaging in left main PCI

23 May 2025 – From EuroPCR 2025

Discover the essential role of intravascular imaging, particularly IVUS, in guiding left main PCI. Case studies highlight real-time guidance, management of complex bifurcation lesions, and strategies for stent failure, emphasizing imaging's impact on procedural outcomes.

Essential role of imaging in left main PCI

Innovative approaches to refractory heart failure: devices and therapies to the rescue

23 May 2025 – From EuroPCR 2025

This session highlights innovative device-based therapies for refractory heart failure, emphasizing the integration of neuromodulation, decongestive strategies, and the synergy with pharmacological treatments. Case presentations illustrate the evolving landscape of advanced heart failure management.

Innovative approaches to refractory heart failure: devices and therapies to the rescue

Management of bifurcations with complex anatomy - part 2

23 May 2025 – From EuroPCR 2025

Explore advanced techniques for managing bifurcations with complex anatomy. This session covers novel guidewire penetration methods, cutting balloon fenestration for dissections, rotatripsy for calcified nodules, and precision wiring in challenging left anterior descending artery curves.

Management of bifurcations with complex anatomy - part 2

How coronary physiology may help in guiding treatment of NSTEMI

23 May 2025 – From EuroPCR 2025

This session explores the utility of coronary physiology in guiding NSTEMI treatment. Topics include ischemia with non-obstructive arteries, QFR quality assessment, FFR-CT impact, revascularization deferral, and sex differences in FFR-guided strategies for acute myocardial infarction with multivessel disease.

How coronary physiology may help in guiding treatment of NSTEMI

Permanent pacing after TAVI

23 May 2025 – From EuroPCR 2025

Explore predictors and mechanisms leading to permanent pacemaker implantation after TAVI. This session reviews electrophysiological intervals, atrial pacing markers, anatomical risk factors, and outcomes associated with new generation transcatheter heart valves.

Permanent pacing after TAVI

TAVI in difficult scenarios: bicuspid anatomy and pure aortic regurgitation

22 May 2025 – From EuroPCR 2025

Address challenging TAVI scenarios involving bicuspid anatomy and pure aortic regurgitation with insights from international experiences. This session compares treatment options in China and Germany, explores anatomical and disease differences, and reviews various TAVI devices through detailed case presentations and expert commentary.

TAVI in difficult scenarios: bicuspid anatomy and pure aortic regurgitation

Atherectomy for CTO-PCI

22 May 2025 – From EuroPCR 2025

Explore atherectomy applications in CTO-PCI with cases demonstrating reverse cart technique, orbital atherectomy in heavily calcified occlusions, and management of atherectomy-induced coronary dissection. Gain practical insights into navigating complex CTO lesions with atherectomy support.

Atherectomy for CTO-PCI

Building bridges, not barriers: transforming communication with patients

22 May 2025 – From EuroPCR 2025

Enhance your communication skills with patients undergoing interventional cardiology procedures. This session emphasizes verbal and non-verbal techniques to inform and support patients, simplifying complex procedural explanations, and strengthening your role as the critical link between patients and the healthcare team for improved outcomes.

Building bridges, not barriers: transforming communication with patients

Antiplatelet strategies for patients undergoing PCI

22 May 2025 – From EuroPCR 2025

Delve into this comprehensive session focusing on antiplatelet strategies for patients undergoing PCI. Explore evidence and clinical insights on ticagrelor monotherapy post-AMI stenting, shortened dual antiplatelet therapy (DAPT) durations, the role of CYP2C19 genotyping in stent thrombosis risk, the effectiveness of dual antithrombotic therapy in atrial...

Antiplatelet strategies for patients undergoing PCI

Outcome prediction using artificial intelligence and meta-analysis

22 May 2025 – From EuroPCR 2025

This session presents outcome prediction advancements through artificial intelligence and meta-analysis in cardiology. Topics include AI-guided aortic stenosis risk stratification, predictors of periprocedural stroke after TAVI, patient-specific computer simulations for bicuspid TAVI, and enhancements in large language model accuracy using Heart Team simulation.

Outcome prediction using artificial intelligence and meta-analysis

Radiation protection: the good and the bad

22 May 2025 – From EuroPCR 2025

This session provides essential guidance on radiation protection in the cath lab. Learn practical steps to minimize radiation exposure for yourself and your team, manage the ergonomic challenges of protective gear, and develop skills to foster a culture of radiation safety within your workplace. Understand the...

Radiation protection: the good and the bad

Imaging makes it clear!

22 May 2025 – From EuroPCR 2025

Explore the critical role of intravascular imaging in interventional cardiology through real-world cases. This session highlights the value of intravascular ultrasound (IVUS) in avoiding unnecessary stenting in STEMI patients, the application of optical coherence tomography (OCT) in complex scenarios, and the management of calcified lesions with...

Imaging makes it clear!

Managing ischaemic and bleeding risk of NSTEMI patients

22 May 2025 – From EuroPCR 2025

Gain valuable insights into managing ischemic and bleeding risks in NSTEMI patients. This session reviews optimal timing for invasive strategies, variability in care processes, radial access approaches, and innovative antithrombotic strategies such as aspirin omission and prasugrel monotherapy to minimize bleeding while optimizing outcomes.

Managing ischaemic and bleeding risk of NSTEMI patients

Catheter-directed therapy for intermediate-high-risk and high-risk pulmonary embolism; where do we stand?

22 May 2025 – From EuroPCR 2025

Explore the evolving landscape of catheter-directed therapy for intermediate-high and high-risk pulmonary embolism. This session covers patient selection criteria, clinical signs indicating the need for intervention, management of potential complications, and ongoing studies shaping future treatments. Case-based discussions illustrate practical applications and key learnings.

Catheter-directed therapy for intermediate-high-risk and high-risk pulmonary embolism; where do we stand?

Patients with degenerated aortic bioprothesis - Every case is different

22 May 2025 – From EuroPCR 2025

Delve into the nuanced management of patients with degenerated aortic bioprostheses, emphasizing that no two cases are alike. This session provides expert insights into selecting optimal valve-in-valve TAVI approaches tailored to individual anatomy and clinical context. Learn practical strategies to overcome complex challenges such as coronary...

Patients with degenerated aortic bioprothesis - Every case is different
Didn’t find what you were looking for?